Refractory Angina Market Global Forecasts Up to 2017-2025: Ark Therapeutics Group Plc, Neovasc Inc., Saneron CCEL Therapeutics, Inc.
Refractory angina refers to a debilitating cardiovascular condition characterized by the inability of arteries to supply the desired volume of blood to the heart.
View full press release